Lv1
46 积分 2026-02-01 加入
SIK2 inhibitor SIC-19 enhances the sensitivity of PARP inhibitors in triple-negative breast cancers and pancreatic cancers
19天前
已完结
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer
24天前
已完结
The Art of Finding the Right Drug Target: Emerging Methods and Strategies
1个月前
已完结
Target identification and assessment in the era of AI
1个月前
已完结
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
1个月前
已完结
Therapeutic targeting of RAS-mediated resistance in oncogene-driven lung cancer
1个月前
已完结
Acquired Resistance to KRASG12C Inhibition in Cancer
2个月前
已完结
Classification of KRAS -Activating Mutations and the Implications for Therapeutic Intervention
2个月前
已完结
Genomic landscape of clinically acquired resistance alterations in patients treated with KRASG12C inhibitors
3个月前
已完结
Predicting Resistance to Small Molecule Kinase Inhibitors
3个月前
已完结
皖公网安备34019202002308
